Ovarian Cancer

Larry Marnett and colleagues have developed what may become the first agent for targeted PET imaging of cancer tissues, such as ovarian cancer, that express high levels of the COX-1 enzyme. Read More

The annual Chic Awearness fundraising event that supports ovarian cancer research at major medical centers, including Vanderbilt University Medical Center (VUMC), will be held Monday, Sept. 25, 6:30 – 8:30 p.m., at Prima Restaurant, 700 12th Ave. South. Read More

Blood type A was associated with longer ovarian cancer survival in a recent Vanderbilt-led study. Read More

The Vanderbilt-Ingram Cancer Center (VICC) announces a funding opportunity to catalyze innovative, collaborative ovarian cancer-related projects. Read More

Listening to the body and being aware of individual risks are especially important when it comes to ovarian cancer. Vanderbilt–Ingram Cancer Center provides the facts. Read More

Fall fashions for women will be on display during the 4th Annual Chic Awearness Fashion Show promoting ovarian cancer awareness and research. The event, to be held Monday, Sept. 26, 6:30 to 8:30 p.m., will benefit the T.J. Martell Foundation, which supports ovarian cancer research at Vanderbilt-Ingram Cancer Center (VICC). Read More

Combining inhibitors of the BMP signaling pathway with standard chemotherapy drugs may overcome drug resistance in ovarian cancer. Read More

Vanderbilt University may nominate one candidate for the Mary Kay Foundation Translational Cancer Research Grant program for 2016. Read More

Drugs that target DNA damage improve ovarian cancer cell response to platinum chemotherapies, suggesting new therapeutic opportunities. Read More

The Kay Yow Cancer Fund, in partnership with the Women’s Basketball Coaches Association and The V Foundation for Cancer Research, has awarded a $100,000 ovarian cancer research grant to the Vanderbilt-Ingram Cancer Center. Read More

Vanderbilt University may nominate one candidate for the Mary Kay Foundation Translational Cancer Research Grant program for 2014. These awards provide $100,000 over two years for investigators involved in translational research in ovarian, uterine, breast or cervical cancer. The Mary Kay Foundation seeks to fund innovative research that will provide… Read More

Vanderbilt researchers have used bioinformatics analysis of gene expression data to describe molecular “circuits” that drive ovarian cancer. Read More

The nuclear receptor TR3 contributes to ovarian cancer cell death in response to platinum-based chemotherapy – and may be a good target for overcoming cell resistance to certain treatments. Read More

Renowned pediatric surgeon, scientist and Harvard Medical School’s first female professor of surgery Patricia K. Donahoe will address the Section of Surgical Sciences’ 55th Barney Brooks Lecture, Friday, May 10, at 7 a.m. in 208 Light Hall. Read More

Combining another drug with platinum-based chemotherapies may be more effective against ovarian cancer. Read More